收费全文 | 3589篇 |
免费 | 236篇 |
国内免费 | 16篇 |
耳鼻咽喉 | 20篇 |
儿科学 | 142篇 |
妇产科学 | 104篇 |
基础医学 | 426篇 |
口腔科学 | 75篇 |
临床医学 | 351篇 |
内科学 | 859篇 |
皮肤病学 | 84篇 |
神经病学 | 195篇 |
特种医学 | 155篇 |
外科学 | 432篇 |
综合类 | 86篇 |
一般理论 | 5篇 |
预防医学 | 253篇 |
眼科学 | 91篇 |
药学 | 309篇 |
中国医学 | 14篇 |
肿瘤学 | 240篇 |
2023年 | 41篇 |
2022年 | 112篇 |
2021年 | 164篇 |
2020年 | 88篇 |
2019年 | 138篇 |
2018年 | 183篇 |
2017年 | 87篇 |
2016年 | 111篇 |
2015年 | 103篇 |
2014年 | 143篇 |
2013年 | 219篇 |
2012年 | 274篇 |
2011年 | 212篇 |
2010年 | 156篇 |
2009年 | 131篇 |
2008年 | 178篇 |
2007年 | 201篇 |
2006年 | 195篇 |
2005年 | 157篇 |
2004年 | 136篇 |
2003年 | 107篇 |
2002年 | 90篇 |
2001年 | 35篇 |
2000年 | 34篇 |
1999年 | 35篇 |
1998年 | 39篇 |
1997年 | 43篇 |
1996年 | 42篇 |
1995年 | 26篇 |
1994年 | 33篇 |
1993年 | 26篇 |
1992年 | 29篇 |
1991年 | 18篇 |
1990年 | 23篇 |
1989年 | 19篇 |
1988年 | 19篇 |
1987年 | 22篇 |
1986年 | 25篇 |
1985年 | 20篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 6篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 6篇 |
1976年 | 13篇 |
1973年 | 8篇 |
1971年 | 5篇 |
Background
The placement of a central venous catheter for the administration of vasopressors is still recommended and required by many institutions because of concern about complications associated with peripheral administration of vasopressors.Objective
Our aim was to determine the incidence of complications from the administration of vasopressors through peripheral venous catheters (PVC) in patients with circulatory shock, and to identify the factors associated with these complications.Methods
This was a prospective, observational study conducted in the emergency department (ED) of a tertiary care medical center. Patients presenting to the ED with circulatory shock and in whom a vasopressor was started through a PVC were included. Research fellows examined the i.v. access site for complications twice daily during the period of peripheral vasopressor administration, then daily up to 48 h after treatment discontinuation or until the patient expired.Results
Of the 55 patients that were recruited, 3 (5.45% overall, 6% of patients receiving norepinephrine) developed complications; none were major. Two developed local extravasation and one developed local thrombophlebitis. All three complications occurred during the vasopressor infusion, none in the 48 h after discontinuation, and none required any medical or surgical intervention. Two of the three complications occurred in the hand, and all occurred in patients receiving norepinephrine and with 20-gauge catheters.Conclusions
The incidence of complications from the administration of vasopressors through a PVC is small and did not result in significant morbidity in this study. Larger prospective studies are needed to better determine the factors that are associated with these complications, and identify patients in whom this practice is safe. 相似文献Around one third of schizophrenia patients are non-responders to antipsychotic therapy. The present study aimed to delineate the pathway-phenotypes of non-remitters (NRTT) and partial remitters (PRTT) to treatment with antipsychotics as defined using the Global Clinical Impression scales. We recruited 60 NRTT, 50 PRTT and 43 healthy controls and measured schizophrenia symptoms, neurocognitive tests, plasma CCL11, interleukin-(IL)-6, IL-10, Dickkopf protein 1 (DKK1), high mobility group box-1 protein (HMGB1), κ- and μ-opioid receptors (KOR and MOR, respectively), endomorphin-2 (EM-2), and β-endorphin. Soft independent modeling of class analogy (SIMCA) showed that NRTT and PRTT are significantly discriminated with a cross-validated accuracy of 94.7% and are qualitatively distinct classes using symptomatome, and neuro-immune-opioid-cognitome (NIOC) features as modeling variables. Moreover, a NIOC pathway phenotype discriminated PRTT from healthy controls with an accuracy of 100% indicating that PRTT and controls are two qualitative distinct classes. Using NIOC features as discriminatory variables in SIMCA showed that all PRTT were rejected as belonging to the normal control class and authenticated as belonging to their target class. In conclusion, a non-response to treatment can best be profiled using a SIMCA model constructed using symptomatome and NIOC features. A partial response should be delineated using SIMCA by authenticating patients as controls or PRTT instead of using scale-derived cut-off values or a number of scale items being rated mild or better. The results show that PRTT is characterized by an active NIOC pathway phenotype and that both NRTT and PRTT should be treated by targeting neuro-immune and opioid pathways.
相似文献